Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
ONCYOncolytics Biotech (ONCY) Prnewswire·2024-06-12 22:22

USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2024 /PRNewswire/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita increases in the incidence of leading cancers, including the very deadly pancreatic cancer, compared to previous generations. The startling revelations come from a study conducted by experts at the National Cancer ...